Next Article in Journal
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
Next Article in Special Issue
Plasma Membrane Ca2+ ATPase Isoform 4 (PMCA4) Has an Important Role in Numerous Hallmarks of Pancreatic Cancer
Previous Article in Journal
Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent Cohort
Previous Article in Special Issue
A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Targeting Calcium Signalling in Malignant Mesothelioma †

1
DiSIT-Dipartimento di Scienze e Innovazione Tecnologica, University of Piemonte Orientale, Viale Teresa Michel 11, 15121 Alessandria, Italy
2
Dipartimento di Scienze e Innovazione Tecnologica, University of Piemonte Orientale, Piazza Sant’Eusebio 5, 13100 Vercelli, Italy
3
Department of Biology and Biotechnology “L. Spallanzani”, University of Pavia, 27100 Pavia, Italy
*
Author to whom correspondence should be addressed.
Dedicated to the memory of Prof. Pier Giacomo Betta.
Cancers 2019, 11(12), 1839; https://doi.org/10.3390/cancers11121839
Submission received: 11 September 2019 / Revised: 18 November 2019 / Accepted: 19 November 2019 / Published: 21 November 2019
(This article belongs to the Special Issue Targeting Calcium Signaling in Cancer Cells)

Abstract

Calcium ions (Ca2+) are central in cancer development and growth, serving as a major signaling system determining the cell’s fate. Therefore, the investigation of the functional roles of ion channels in cancer development may identify novel approaches for determining tumor prognosis. Malignant mesothelioma is an aggressive cancer that develops from the serosal surface of the body, strictly related to asbestos exposure. The treatment of malignant mesothelioma is complex and the survival outcomes, rather than the overall survival data are, to date, disappointedly daunting. Nevertheless, conventional chemotherapy is almost ineffective. The alteration in the expression and/or activity of Ca2+ permeable ion channels seems to be characteristic of mesothelioma cells. In this review, we explore the involvement of the Ca2+toolkit in this disease. Moreover, the established sensitivity of some Ca2+channels to selective pharmacological modulators makes them interesting targets for mesothelioma cancer therapy.
Keywords: Ca2+ channel; Ca2+ toolkit; Cancer; Mesothelioma; Signalling pathway Ca2+ channel; Ca2+ toolkit; Cancer; Mesothelioma; Signalling pathway

Share and Cite

MDPI and ACS Style

Martinotti, S.; Patrone, M.; Moccia, F.; Ranzato, E. Targeting Calcium Signalling in Malignant Mesothelioma. Cancers 2019, 11, 1839. https://doi.org/10.3390/cancers11121839

AMA Style

Martinotti S, Patrone M, Moccia F, Ranzato E. Targeting Calcium Signalling in Malignant Mesothelioma. Cancers. 2019; 11(12):1839. https://doi.org/10.3390/cancers11121839

Chicago/Turabian Style

Martinotti, Simona, Mauro Patrone, Francesco Moccia, and Elia Ranzato. 2019. "Targeting Calcium Signalling in Malignant Mesothelioma" Cancers 11, no. 12: 1839. https://doi.org/10.3390/cancers11121839

APA Style

Martinotti, S., Patrone, M., Moccia, F., & Ranzato, E. (2019). Targeting Calcium Signalling in Malignant Mesothelioma. Cancers, 11(12), 1839. https://doi.org/10.3390/cancers11121839

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop